Biosimilars: From Science to Practice in Cancer Care – UCL

Access the course here: https://www.ucl.ac.uk/pharmacy/study/professional-development/biosimilars-science-practice-cancer-care

In this expert authored eLearning module, our team at UCL School of Pharmacy, collaborating with pharmacists at University College London and The Royal Marsden Hospital, will take you through the scientific knowledge needed in the adoption of biosimilar medicines.

Learning objectives

On completion of the eLearning module, you will be able to:

  • Demonstrate your understanding of the difference between biologic and chemical drugs.
  • Improve your understanding of biosimilars vs generics in terms of characteristics of structure and the clinical trials required.
  • Demonstrate knowledge of comparability studies and regulatory data.
  • Improve knowledge of practical aspects of adopting biosimilars – storage and stability differences.
  • Show understanding of patient considerations eg. revised consent, adverse reactions and patient information.
  • Improve confidence in handling clinician concerns prior to uptake.

Join this course

The course is free to access. Please click here to enrol. You will be taken to a webpage where you need to click ‘Select’. After this you will need to log in if you have a UCL Extend Account, or create a new account.

If you have any queries about the course please contact Pinkie Chambers at [email protected]

Follow the Twitter handle @UCLbiosimilar to join in with the discussion, ask questions and stay up to date with recent developments.

Latest News

By BOPA on 16th April 2024

Abstract Submission for #BOPA2024 is NOW OPEN

Abstract Submission for the 27th Annual BOPA Conference in 2024 is now OPEN   Delegates are invited to present results of their clinical and technical work as a poster with…

Read article
By BOPA Research Subcommittee on 15th April 2024

Survey: Service Evaluation on Carboplatin Variation in UK

We invite members to complete this service evaluation to understand national variations in carboplatin dosing for adult patients receiving SACTs. We are looking at whether we can standardise carboplatin protocols…

Read article
By BOPA on 11th April 2024

My Research Webinar – April 2024

Thursday 25th April 2024 1-2pm BST   Register for the Session HERE: https://www.bopa.org.uk/webinarsignupform/   We would like to invite you to join our  ‘My Research’ sessions. These sessions are delivered…

Read article
By BOPA Committee on 10th April 2024

Independent UK Pharmacy Professional Leadership Advisory Board launched to strengthen collaboration

BOPA is proud to be part of the UK PPL Board and represent all Pharmacy Professionals and Cancer Pharmacy Professionals across the UK. For more information see the letter on…

Read article